UNSPSC 51284132: Cefmenoxime hydrochloride

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NON736D32W. European Medicines Agency schedules Cefmenoxime hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01117MIG. Cefmenoxime hydrochloride generally arises in the molecular formula 2C16H17N9O5S3.CLH. The term 'cefmenoxime hydrochloride' is a United States Adopted Name designation.

UNSPSC 51284132 Cefmenoxime hydrochloride is a Commodity code that represents a specific branded or generic pharmaceutical product, but recent state and local opportunities tagged with this code actually solicit broader medical supply categories—naloxone, first-aid supplies, generic multi-source pharmaceuticals, and over-the-counter products—rather than cefmenoxime specifically. The code appears misaligned with the actual procurement activity it is receiving. State and local governments buying under this code are seeking medical supplies for emergency response, community health, and pharmacy benefit programs. Issuing bodies include county health departments, city fire departments, state health and human services commissions, and multistate cooperative purchasing alliances. The work involves competitive bidding for pharmaceutical products, emergency medical supplies, and pharmacy benefit management services, with vendors required to meet FDA compliance, Good Manufacturing Practices certification, Drug Supply Chain Security Act requirements, and established delivery timelines.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The City of Tampa issued ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division, valued at $700,000, with a 5 percent bid discount for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, including Oregon. The Texas Health and Human Services Commission issued RFI HHS0017013 (due April 3, 2026) to explore direct-to-manufacturer prescription programs for self-insured employee health plans. The code shows moderate fragmentation across county, city, state, and multi-state buyers with no single dominant issuer.